Health  Vol.4 No.9 , September 2012
Antibacterial activity of Ampicillin trihydrate formulated in Aluminium-Magnesium Silicate, against Salmonella gallinarum
Abstract: To test if stabilizing Ampicillin trihydrate (AT) with Aluminium-Magnesium Silicate (AMS) can enhance its antibacterial activities, different concentrations of AT solution and of a formulation of AT in the AMS, were made and used for sensitivity test on Salmonella gallinarum cultures. Also, S. gallinarum-infected chicks were treated with; 10 mg/Kg (AT), 10 mg/Kg (AT in AMS), 7.5 mg/Kg (AT), 7.5 mg/Kg (AT in AMS). Mean diameter of inhibition zone, 28.39 ± 2.07 mm produced by AT did not vary significantly (P > 0.05) from 26.36 ± 2.05 mm produced by AT in AMS. However, mean Salmonella gallinarum culture forming units per ml of bile, 17.6 ± 11 × 105of the untreated chicks and 3.4 ± 0.81 × 105(80.58% reduction), 2.4 ± 0.67 × 105(85.70% reduction), 5.4 ± 1.93 × 105(69.20% reduction ) and 0.38 ± 0.13 × 105(97.80% reduction ) of the respective treated groups, showed AMS significantly (P < 0.01) improved AT’s ability to clear S. gallinarum infection, in vivo.
Cite this paper: Ezeibe, M. , Anosa, G. , Okorie, O. , Elendu-Eleke, N. , Okoroafor, O. , Ngene, A. and Chikelu, O. (2012) Antibacterial activity of Ampicillin trihydrate formulated in Aluminium-Magnesium Silicate, against Salmonella gallinarum. Health, 4, 675-678. doi: 10.4236/health.2012.49106.

[1]   Crump, J.A., Luby, S.P. and Mintz, E.D. (2004) The global burden of typhoid fever. Bulletin of the World Health Organization, 82, 346-353.

[2]   Klotchko, A. and Walace, M.R. (2009) Salmonellosis.

[3]   CDC (2009) Preliminary food net data on the incidence of infection with pathogens transmitted commonly through food—10 statea. MMWR Morbidity and Mortality Weekly Report, 59, 418-422.

[4]   CDC (2010) Salmonellosis. MMWR Morbidity and Mortality Weekly Report 2009, 58, 25-29.

[5]   Helms, M., Simonsen, J. and Molbak, K. (2004). Quinolone resistance is associated with increased risk of invasive illness or death during infection with Salmonella serotype Typhimurium. Journal of Infectious Diseases, 190, 1652-1654. doi:10.1086/424570

[6]   Gunderson, B.W., Ross, G.H., Ibrahim, K.H. and Rotschafer, J.C. (2001) What do we really know about antibiotics pharmacodynamics? Pharmacotherapy, 21, 302S-318S.

[7]   Aiello, S.E. (1998) Merck veterinary manual. 8th Edition, Merk and Co. Inc., Whitehouse Station.

[8]   Wai, K.-N., Dekay, H.G. and Banker, G.S. (1996). Application of montmorrillonitse in tablet making. Journal of Pharmaceutical Sciences, 55, 1244-1248. doi:10.1002/jps.2600551116

[9]   Vanderbilt, T.I. (1992). Veegum—The versatile ingredient for pharmaceutical formulations. Inc. Tecnical Literature.

[10]   Schills, S. (2002) The use of clay in fight against effect of ammonia.

[11]   Elmore, A.R. (2003) Cosmetics ingredients review experts panel’s report. International Journal of Toxicology, 22, 37-102.

[12]   Ezeibe, M.C.O. (2006) Admacine. Federal Republic of Nigeria. Patents and Design Act. Cap. 344. LDN. 1990. No. 16448.

[13]   Ezeibe, M.C.O., Okafor, U.C., Okoroafor, O.N., Eze, J.I., Ngene, A.A., Animoke, P.C. and Mbuko, I.J. (2011) Effect of Aluminium-Magnesium Silicate on anticcocidial activity of sulphadimidin. Tropical Veterinarian, 29, 41-44.

[14]   Ezeibe, M.C.O., Elendu-Eleke, N.P., Okoroafor, O.N. and Ngene, A.A. (2012) Adjuvant effect of a synthetic Aluminium-Magnesium Silicate on chloroquine phosphate, against Plasmodium berghei. Health, 4, 448-451.

[15]   Ezeibe, M.C.O., Dire, C.D., Anosa, G.N., Chikelu, O.N., Okoroafor, O.N., Okorie, O.K., Ngene, A.A., Idika, I.K., Ogunniran,T.M. and Ezeala, I.E. (2012) Efficacy of piperzine citrate, stabilized with Aluminium-Magnesium silicate, against Helignosomoides bakeri. Health (Accepted for Publicatio).